科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/03/30 | 3,945 | 3,965 | 3,900 | 3,945 | -120 | -3% | 181,400 |
| 2022/03/29 | 4,065 | 4,070 | 4,005 | 4,065 | +10 | +0.2% | 88,700 |
| 2022/03/28 | 4,060 | 4,080 | 4,025 | 4,055 | +35 | +0.9% | 82,600 |
| 2022/03/25 | 3,990 | 4,020 | 3,965 | 4,020 | +60 | +1.5% | 136,800 |
| 2022/03/24 | 3,990 | 4,025 | 3,935 | 3,960 | -80 | -2% | 154,800 |
| 2022/03/23 | 3,960 | 4,045 | 3,940 | 4,040 | +100 | +2.5% | 173,900 |
| 2022/03/22 | 3,955 | 3,990 | 3,880 | 3,940 | +5 | +0.1% | 314,000 |
| 2022/03/18 | 4,180 | 4,180 | 3,935 | 3,935 | -260 | -6.2% | 189,700 |
| 2022/03/17 | 4,270 | 4,270 | 4,180 | 4,195 | -5 | -0.1% | 84,700 |
| 2022/03/16 | 4,135 | 4,235 | 4,130 | 4,200 | +65 | +1.6% | 97,100 |
| 2022/03/15 | 4,075 | 4,150 | 4,070 | 4,135 | +85 | +2.1% | 59,500 |
| 2022/03/14 | 4,135 | 4,145 | 4,035 | 4,050 | -85 | -2.1% | 67,600 |
| 2022/03/11 | 4,160 | 4,185 | 4,135 | 4,135 | -75 | -1.8% | 60,900 |
| 2022/03/10 | 4,190 | 4,220 | 4,160 | 4,210 | +75 | +1.8% | 109,600 |
| 2022/03/09 | 4,100 | 4,145 | 4,100 | 4,135 | +5 | +0.1% | 77,600 |
| 2022/03/08 | 4,125 | 4,155 | 4,110 | 4,130 | +10 | +0.2% | 103,400 |
| 2022/03/07 | 4,110 | 4,125 | 4,085 | 4,120 | +5 | +0.1% | 68,200 |
| 2022/03/04 | 4,130 | 4,180 | 4,115 | 4,115 | -50 | -1.2% | 53,800 |
| 2022/03/03 | 4,105 | 4,195 | 4,105 | 4,165 | +70 | +1.7% | 75,300 |
| 2022/03/02 | 4,130 | 4,155 | 4,090 | 4,095 | -105 | -2.5% | 122,400 |
| 2022/03/01 | 4,240 | 4,250 | 4,195 | 4,200 | -20 | -0.5% | 51,500 |
| 2022/02/28 | 4,135 | 4,230 | 4,135 | 4,220 | +115 | +2.8% | 55,000 |
| 2022/02/25 | 4,165 | 4,190 | 4,085 | 4,105 | -45 | -1.1% | 38,500 |
| 2022/02/24 | 4,100 | 4,160 | 4,080 | 4,150 | +30 | +0.7% | 45,000 |
| 2022/02/22 | 4,120 | 4,140 | 4,105 | 4,120 | -20 | -0.5% | 55,200 |
| 2022/02/21 | 4,160 | 4,165 | 4,120 | 4,140 | -75 | -1.8% | 44,800 |
| 2022/02/18 | 4,215 | 4,240 | 4,180 | 4,215 | +10 | +0.2% | 36,300 |
| 2022/02/17 | 4,300 | 4,305 | 4,200 | 4,205 | -100 | -2.3% | 46,600 |
| 2022/02/16 | 4,305 | 4,320 | 4,280 | 4,305 | +65 | +1.5% | 66,000 |
| 2022/02/15 | 4,250 | 4,275 | 4,220 | 4,240 | +5 | +0.1% | 51,100 |
| 2022/02/14 | 4,180 | 4,240 | 4,140 | 4,235 | +40 | +1% | 72,800 |
| 2022/02/10 | 4,160 | 4,205 | 4,160 | 4,195 | +35 | +0.8% | 98,200 |
| 2022/02/09 | 4,160 | 4,170 | 4,140 | 4,160 | +20 | +0.5% | 59,300 |
| 2022/02/08 | 4,125 | 4,170 | 4,125 | 4,140 | +35 | +0.9% | 59,000 |
| 2022/02/07 | 4,070 | 4,130 | 4,070 | 4,105 | +10 | +0.2% | 64,300 |
| 2022/02/04 | 4,105 | 4,115 | 4,050 | 4,095 | -95 | -2.3% | 91,900 |
| 2022/02/03 | 4,200 | 4,225 | 4,180 | 4,190 | -10 | -0.2% | 58,300 |
| 2022/02/02 | 4,150 | 4,210 | 4,140 | 4,200 | +55 | +1.3% | 52,100 |
| 2022/02/01 | 4,100 | 4,175 | 4,095 | 4,145 | +45 | +1.1% | 57,000 |
| 2022/01/31 | 4,180 | 4,180 | 4,085 | 4,100 | -105 | -2.5% | 92,100 |
| 2022/01/28 | 4,210 | 4,230 | 4,185 | 4,205 | +60 | +1.4% | 61,300 |
| 2022/01/27 | 4,195 | 4,215 | 4,125 | 4,145 | -25 | -0.6% | 88,100 |
| 2022/01/26 | 4,240 | 4,240 | 4,160 | 4,170 | -55 | -1.3% | 53,800 |
| 2022/01/25 | 4,215 | 4,260 | 4,195 | 4,225 | -50 | -1.2% | 66,300 |
| 2022/01/24 | 4,180 | 4,280 | 4,180 | 4,275 | +40 | +0.9% | 75,800 |
| 2022/01/21 | 4,215 | 4,235 | 4,175 | 4,235 | +25 | +0.6% | 71,300 |
| 2022/01/20 | 4,230 | 4,275 | 4,195 | 4,210 | -15 | -0.4% | 92,700 |
| 2022/01/19 | 4,220 | 4,260 | 4,210 | 4,225 | -35 | -0.8% | 87,100 |
| 2022/01/18 | 4,330 | 4,335 | 4,245 | 4,260 | -40 | -0.9% | 58,300 |
| 2022/01/17 | 4,295 | 4,345 | 4,270 | 4,300 | -20 | -0.5% | 50,000 |
801～
850
件表示中 / 3735件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 379,000円 | -6.4% | -71.8% | 5.01% | 42.33倍 | 0.94倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| キッセイ薬 | 399,000円 | +3.6% | +6.1% | 3.01% | 13.44倍 | 0.79倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 鳥居薬 | 632,000円 | +7.1% | -35.0% | 0.00% | 52.26倍 | 1.46倍 |
|
ＪＴ傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がＴＯＢ実施 |
| ジーエヌアイ | 311,500円 | +21.7% | +999.9% | 0.00% | 13.05倍 | 4.32倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| サンバイオ | 217,100円 | - | - | 0.00% | - | 100.56倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
